June 15, 2011 (Montreal, Quebec City) — Injection of a diagnostic echo-contrast agent in patients undergoing right heart catheterization did not alter baseline pulmonary pressures from baseline levels ...
PRINCETON, NJ, June 13, 2011 – Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison™ (Perflutren Protein-Type A Microspheres ...
Background: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by the presence of telangiectases and arteriovenous malformations. In some families in whom a ...
PPH is a progressive cardiopulmonary disorder that may occur at any age (1). In the American PPH registry, the mean age at onset was 36 y, with a female-to-male ratio of 1.7 to 1 (2). Whereas PPH is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback